Custom Search

Brand Name(s): Rituxan; Mabthera
CAS nº: 174722-31-7
(rih tux ih mab)

What is Rituximab?

Rituximab is a cancer (antineoplastic) medication. It works by interfering with the growth of cancer cells by slowing their growth and spread in the body.

Rituximab is also used in the treatment of non-Hodgkin's lymphoma.

Additionally, this medication can be used alone or in combination with other chemotherapeutic drugs. Specifically, very good results have been seen when used in combination with the CHOP chemotherapy regimen (cyclophosphamide, doxorubicin, vincristine, and prednisone).

Rituximab is sold as Rituxan® in the United States.

See more Product Info

Latest News

Cancer Drug Slows Multiple Sclerosis Progression

Two shots of the cancer drug Rituxan given two weeks apart slowed the progression of multiple...


Role of Mitoxantrone in Combination Therapy for Chronic Lymphocytic Leukemia (CLL) Evaluated

Researchers from Spain have reported preliminary results of initial treatment of patients with...


MabThera(REG) Helps Patients With Lymphoma Stay Symptom Free And Live Longer

A study published recently in Blood, the journal of the American Society of Hematology, has...


FDA Issues Safety Warning On Biogen Drug; Stock Is Falling

Monday, the U.S. Food and Drug Administration or FDA issued a warning to healthcare professionals...


Use of this site is subject to the following terms of use